A Phase II Study of Sunitinib Malate (Sutent) With Paclitaxel (Taxol) in Patients With Advanced Esophageal Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Sunitinib (Primary) ; Paclitaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 16 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Sep 2008 New trial record.